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Abstract: This article presents an integrated epidemiological and economic framework for assessing zoonoses
using a ‘‘one health’’ concept. The framework allows for an understanding of the cross-sector economic impact
of zoonoses using modified risk analysis and detailing a range of analytical tools. The goal of the framework is
to link the analysis outputs of animal and human disease transmission models, economic impact models and
evaluation of risk management options to gain improved understanding of factors affecting the adoption of
risk management strategies so that investment planning includes the most promising interventions (or sets of
interventions) in an integrated fashion. A more complete understanding of the costs of the disease and the costs
and benefits of control measures would promote broader implementation of the most efficient and effective
control measures, contributing to improved animal and human health, better livelihood outcomes for the poor
and macroeconomic growth.
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INTRODUCTION
Zoonotic diseases are caused by many different pathogenic
agents. In most cases, humans are accidental or ‘‘spill-over’’
hosts of a disease-ecological cycle maintained by animal
hosts, including insects (Kayali et al. 2003; Schelling et al.
2003). Because of the circulation of zoonotic agents be-
tween animals, humans, and the environment, the cost of a
disease affects human activity and health in addition to
other economic sectors. According to the Institute of
Medicine (2009), zoonotic pathogens caused more than
65% of emerging infectious disease events in the past six
decades. The direct cost of zoonotic diseases over the last
decade has been estimated to be more than $20 billion with
over $200 billion indirect losses to affected economies as a
whole (World Bank 2010). In the last 60 years, many
industrialized countries have successfully controlled or
eliminated zoonotic diseases through costly public invest-
ment facilitating coordinated interventions, including ‘‘test
and slaughter,’’ feed bans, mass vaccination of domestic
animals and wildlife, health education and milk pasteuri-
zation. These are highly effective methods of eliminating
zoonotic diseases which require important operational, le-
gal, and financial collaterals (Keusch et al. 2009). In most
developing countries, surveillance of zoonotic diseases is
not recognized as ‘‘one-health’’ collaboration between
veterinary medicine and human medicine. In addition,
many countries lack diagnostic capacity and health
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infrastructure. In livestock populations efforts have pri-
marily focused on implementing prevention and eradica-
tion measures with much less emphasis on the effect of
mitigation (transmission control) strategies, taking into
consideration economic and development impacts at the
macro (national economy, environment) or micro (health,
livelihoods, food security of smallholder farmers) levels.
Many industrialized countries are able to control or
reduce the risk of zoonotic diseases through public
investment in preventative measures such as surveillance
and compensation of farmers for culled stock in the event
of an outbreak. In April 2001, the British government
slaughtered and destroyed more than 2 million animals in
England to stop the spread of foot-and-mouth disease
(Sobrino and Domingo 2001). Such interventions are not
feasible in many developing countries because of poor
surveillance programs, limited institutional capacity, and,
without donor assistance, lack of funds for livestock holder
compensation (Zinsstag et al. 2007). This issue is illustrated
by the limited effectiveness of the response following the
HPAI outbreak in 2006–2008. Education programs to in-
crease producer level bio-security measures were imple-
mented in developing countries without careful
consideration of how to alter behavior of small scale pro-
ducers sustainably, despite high level ministerial support
(Narrod et al. 2011). Successful investment in zoonoses
control requires assessment of the cost of disease and the
cost-effectiveness of proposed interventions, in addition to
adaptation of the interventions to the local context. Given
that 70% of the world’s rural poor depend on livestock and
working animals for their livelihoods, animals cannot be
left out of the solutions (LID 1999; FAO 2002).
Cost assessments of zoonoses require in-depth under-
standing of the ecology of disease. Detailed knowledge
about transmission pathways helps identify sectors con-
tributing to the cost of disease and is essential for deter-
mining effective interventions for interruption of the
disease cycle. Zoonoses control is unique in that effective
interventions may lie outside the health sector because
transmission often does not occur between humans, but
only from animals to human like in rabies or brucellosis
(Zinsstag et al. 2005a, 2009b).
Economic impacts exist beyond the cost of control,
including direct decreases in household income due to
reduction in livestock/product sales, consumption impacts
due to reduced food security, increased household vul-
nerability where livestock is used as a risk-coping mecha-
nism and affects on household wealth which influence
savings and gender equality (Birol et al. 2010). In addition
there are impacts at the sector level, such as the feed and
input sector or the broader economy which includes other
analyzable input and output sectors (see You and Diao
2007; Diao et al. 2009). These associated costs may influ-
ence behavioral change at different levels (household,
practitioners, policy) which is important to the decision-
making process.
A ‘‘one health’’ approach demonstrates closer coop-
eration between human and animal health resulting in
benefits that are not achieved through the two medicines
working independently. ‘‘One health’’ evolved from ‘‘one
medicine,’’ a term coined by veterinary epidemiologist
Calvin Schwabe in the 1960s to demonstrate that there is no
paradigm difference between human and veterinary medi-
cine thus allowing for integrated work (Schwabe 1984). To
date, there have been limited efforts to conduct integrated
analyses considering both the social and ecological systems,
although this approach is not conceptually new having
been successfully applied in an ‘‘ecosystem approach to
health’’ or ‘‘ecohealth’’ (Forget and Lebel 2001). We suggest
that such an approach has enormous potential to improve
public and animal health and provide cost savings in the
public and private sectors. Sampling humans and animals
simultaneously in an integrated study design decreases
detection time for zoonotic disease (Schelling et al. 2003;
Zinsstag et al. 2009a). Through integrated analysis, the full
societal cost of disease can be estimated linking an animal–
human transmission model to cross-sector economic
analysis to show the full societal cost (Roth et al. 2003,
Zinsstag et al. 2005a). The cost of livestock mass vaccina-
tion is often much higher than the public health benefit
savings. Singularly from a public health perspective, such
interventions are not cost-effective. An example is brucel-
losis control in Mongolia, where the intervention costs are
less than a third of the overall cost of disease, when the
private and agricultural sectors are included, with a societal
benefit-cost ratio of 3.2 (Roth et al. 2003). Assessing the
cost of zoonoses in multiple sectors facilitates identification
of cost-sharing options such as a separable cost method.
Although brucellosis control by livestock mass vaccination
is not cost-effective from a public health sector perspective,
it becomes highly cost-effective when costs are shared
between the public health and agricultural sectors in pro-
portion to their benefits (Roth et al. 2003). Integrated
assessments are hence crucial for zoonotic disease control
in resource poor countries (Zinsstag et al. 2007). The goal
of the framework is to link the analysis outputs of animal
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and human disease transmission models, economic im-
pact models, and evaluation of risk management options
as a practical tool to gain improved understanding of
factors affecting the adoption of risk management strate-
gies so that investment planning includes the most
promising interventions (or sets of interventions) in an
integrated fashion.
PROPOSED FRAMEWORK
The proposed ‘‘one health’’ framework is a modified risk
analysis (Fig. 1) linking outputs associated with animal
health transmission models, economic impact models, and
risk analysis to inform the planning of investments through
the most promising interventions (or set of interventions)
and improve economic outcomes such as poverty allevia-
tion, food security, and improved livelihoods. This frame-
work allows identifying potentially useful types of analysis
to inform decision makers prior to intervention imple-
mentation. This is valuable as decision makers evaluate
different mitigation techniques to obtain a desired level of
safety at a given cost. At best, mitigation is negotiated with
all stakeholders, communities, authorities, and scientists in
participatory transdisciplinary processes (Schelling 2008;
Zinsstag 2007). Risk managers can choose strategies
depending on the risk preferences for affected stakeholders
and comparative advantages in implementing risk-reduc-
tion options. It is difficult to compare strategies which
consider risk reductions and others evaluating costs and
benefits. Despite good intentions, decisions can lead to
losses in social welfare through unexpected outcomes and
consequences. Decision makers would be aided by a
framework which structures complex information and ac-
counts for implications of the intricacy.
The proposed approach is similar to a traditional risk
assessment, which includes a release assessment (where all
potential pathways for disease introduction are identified),
an exposure assessment (in which all potential pathways for
exposure to the zoonotic disease in animals and humans are
identified) and a consequence assessment. It is similar in that
it also involves analysis to evaluate risk management efforts
in terms of benefit costs and cost-effectiveness. A modifica-
tion is that analyses enabling decision makers to consider
Figure 1. Modified risk analysis framework to enhance reduction of zoonotic disease burden.
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stakeholders behavior modifiers, such as knowledge,
attitude, and perception analysis and willingness to pay/
adoption analysis, are also included. Additionally considered
is an analysis enabling decision makers to understand factors
affecting intervention uptake to assess successful strategies.
A stepwise approach is utilized:
I. Estimate the extent of the disease and potential spread;
II. Estimate the cost of zoonotic disease on livelihoods
outcomes (income, health, and trade), including envi-
ronmental impacts;
III. Assess the cost-effectiveness of risk management
strategies currently employed for reduction of human
and animal zoonotic disease exposure risk;
IV. Identify factors affecting adoption of zoonotic risk
reduction strategies in poor households, the commer-
cial sector and government bodies.
At all steps, participatory stakeholder consultations can
take place which will ascertain perceived risk and mitiga-
tion priorities between all involved stakeholders.
Table 1 summarizes analytical methods for each step
elaborating uses, strengths, and weakness, associated data
requirements and possible users. Each proposed analytical
approach has associated resource issues and it is not nec-
essary to perform all simultaneously. Assembling the
framework ensures that the analyses are integrated from the
outset providing maximum benefit. Outputs of analytical
efforts within the proposed framework will enable decision
makers to evaluate the cost-effectiveness of various control
measures and potential combinations for risk reduction
from different perspectives. Calvin Schwabe’s ‘‘one medi-
cine’’ concept has become more prominent in the last
decade. The modified risk analysis approach described here
correlates but has evolved towards ‘‘one health’’ conceptual
thinking while emphasizing epidemiology and public
health (Zinsstag et al. 2005b). Acceptance is reflected
through adherence by professional organizations, govern-
mental establishment of joint public and animal health
working groups and inception of numerous research and
surveillance programs (Zinsstag et al. 2009a, b). The pro-
posed framework for estimating the societal cost of zoo-
noses is an open tool, translating the ‘‘one health’’ concept
into practical methodology. It is consistent with the ‘‘One
world one health’’ strategy, first defined in 2008, and cur-
rently adopted by the World Bank. The proposed frame-
work is envisioned as a springboard for discussion,
resulting in mutually adopted practical cooperation be-
tween human and animal health with a unique emphasis on
developing countries but also global applicability (Zinsstag
et al. 2009a).
PROPOSED STEPS
Step 1: Estimating the Extent of the Disease and
Potential Spread
Impact of Disease
Zoonoses cause human illness, permanent disability, and
death. Animals may be asymptomatic carriers but can also be
clinically ill or die. In livestock, illness may cause reduction in
productivity, in numbers of live animals (reduced fertility)
and reduced meat and milk production. The pooled impact
of zoonoses on humans and animals to society can be esti-
mated in terms of cost to different sectors.
Burden of Disease Estimate Zoonotic diseases cause losses
in goods produced (live animals, milk, meat, wool) and
disability or loss of human life. The overall burden of disease
to society involves a quantifiable monetary term and a
quantifiable term reflecting loss of human life. Loss of human
life can be quantified using standard life tables to sum the
number of expected life years at the age of death. Non-fatal
disease impairs human life during clinical illness and may
result in temporary or permanent disability. WHO estimate
the level of impairment of ill health and permanent disability
related to complete physical and mental health and well-
being (Disability weight = 0) and to death (Disability
weight = 1). Disability weights of non-fatal diseases are
classified depending on the level of impairment of human life
to engage in occupation, procreation and recreation. This
classification is controversial, raising ethical issues. Alterna-
tive ways of assessing the burden of disease address perceived
quality of life, termed quality adjusted life years (QALYs).
The proposed framework does not directly address this issue,
instead focusing on the development of disability adjusted
life years (DALYs) parameters, as currently in wide use, in
order to increase the probability of effective interventions.
DALY Parameters DALYs are used in the global com-
parative assessments of the burden of disease (Carabin et al.
2005) and enable costs of interventions to be related to a
standardized health outcome across diseases internationally
(Murray 1994; Murray and Acharya 1997). DALYs are a
reflection of the time lived with a disability and the time
lost because of premature death (Formula 1).
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DALYs ¼ years of life lost þ years of life with a disability
ð1Þ
The duration of time lost due to premature death is
calculated by using standard expected years of life lost with
model life tables. The reduction in physical capacity due to
illness is measured by using disability weights, mathemat-
ically expressed in Formula 2 (Murray and Acharya 1997)
 DCe
ba
bþ rð Þ2 e
 bþrð Þ Lð Þ 1þ bþ rð Þ Lþað Þð Þ 1þ bþ rð Það Þ
h i" #
ð2Þ
where a is the age at onset of disease, L is the duration of
disability or time lost due to premature mortality, D is the
disability weight (or 1 for premature mortality), r is the
discount rate, C is the age-weighting correction constant,
and b is the parameter from the age-weighting function.
Methods for Estimating the Initial Prevalence of a Disease
Integrated methods, which investigate human and animal
health simultaneously, are justified if the incremental knowl-
edge generated is higher than two separate human and animal
health studies, and if there are no concessions made with re-
gard to the quality of methods used on either side. The
interfaces between species can be straight forward or at dif-
ferent levels, e.g., by occupational or consumer exposure. In-
depth assessments are then necessary to understand lifecycles
and drivers of reservoir (maintenance host) populations. A
variety of longitudinal and cross-sectional designs exist to
monitor animal–human transmission using proxy indicators,
for example, dog bites in the case of rabies (Cleaveland et al.
2002), questionnaires to determine exposure (Kayali et al.
2003) or comparative seroprevalence in human and potential
animal reservoirs (Schelling et al. 2003; Zinsstag et al. 2009a).
Studies at the animal–human interface should target high risk
human populations within the context of exposure, such as
encroaching habitat, live animal markets, or occupational risk
groups (livestock workers, veterinarians) (Bonfoh et al. 2011).
Step 2: Estimate the Cost of Zoonotic Diseases on
Livelihoods Outcomes and National Economies,
Including Environmental Impacts
Methods for Modeling Transmission
The cost and societal burden of zoonoses can be assessed in
a static way from cross-sectional data. Additionally,T
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benefit–cost analysis or cost-effectiveness of interventions
can be done by comparing cost of disease before and after
interventions, but these approaches do not consider the
time-dependent dynamics of disease transmission with and
without interventions. Zoonoses transmission can be
endemically stable but usually undergoes epidemic cycles
that are not captured by static approaches. Animal to hu-
man transmission is determined by the population
dynamics. Animal–human transmission models are able to
capture nonlinear dynamics in dissemination (Zinsstag
et al. 2005a, 2006, 2009b), allowing human disease burden
to be directly linked to the transmission in animals. A key
feature of such models is that they can be used to simulate
interventions, comparing outcomes with and without
interventions (Fig. 2).
Assessing Effects on Livestock Productivity
Zoonoses affect the individual animal and herd produc-
tivity. Abortions reduce overall fertility of the herd, indi-
rectly determining the number of live animals and
production of meat and milk. To project effects of zoonoses
on livestock production a livestock demographic model like
the Livestock Development Planning System (LDPS;
Figure 2. Flow chart of dog–human rabies transmission (Zinsstag et al. 2009b, with permission).
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www.fao.org/agriculture/lead/tools/livestock0/fr, accessed
September 2011), can be used (Roy 2008; Roth et al. 2003). It
requires information about herd age and sex composition.
This data can be obtained from national statistical offices or
collected from large field surveys. Demographic models are
driven by fertility and age-specific mortality. Fertility is
expressed as number of newborn animals per female animal,
in reproductive age per year. Age-specific mortality is the
number of deaths per age group per year. Prior to simulating
the effect of zoonoses on the demographic composition,
baseline productivity should be simulated with known fer-
tility and age-specific mortality data.
Methods for Modeling the Economic Cost of Disease
Macroeconomic Impact (Roy 2008) The macroeconomic
impact of zoonotic diseases can be modeled using a com-
putable general equilibrium model or multi-market model.
Model choice depends on livestock sector structure and the
extent of structural linkages with other economy sectors
and available data. Disease shocks like an occurrence of
zoonosis can affect availability of livestock supply, for
example through disease control measures such as eradi-
cation of infected animals reducing stock inventory.
Declining production of livestock then affects household
income through revenue losses for livestock keepers thereby
affecting total national income, with decline in sales also
influencing consumer prices.
Zoonotic disease outbreaks also impact the demand side
through reduction in consumption expenditures on livestock
products due to perceived food safety concerns or trade
restrictions. This causes prices to drop, affecting producer
livelihoods through lower returns causing diversion to non-
livestock activities as compensation for falling returns from
livestock. With non-livestock production increasing, prices
for these non-livestock products fall, and thus benefiting other
sectors in the economy. Similar to supply shocks, demand
shocks also affect other sectors of the economy, including
tourism. The net effect of the demand and supply shocks de-
pends on income distribution and economy structure.
The models previously discussed use data from the
national social accounting matrix, household budget sur-
vey, and household living standard survey and type of
livestock commodity. If data are available at individual or
farm level, a micro-simulation can determine the effect of
disease shocks or risk mitigating/control measures on
individuals’ income, wealth, and nutrition.
Macroeconomic models can be further integrated with
available spatial disease spread models which reflect disease
transmission. Spatial spread models are usually based on
state and transition probabilities assessing the risk severity
of disease outbreaks. Transition probabilities depend on
transmission routes of infected livestock and trade flows (in
country, cross-border) of the livestock products. To be
useful, all data must be at the same aggregation level. In
situations where actual data are not known, a series of
simulations are projected using different levels of demand
and supply shocks, e.g., varying dimensions of outbreak
severity (minor: 15% to major: 30%), spread (local,
nationwide) and duration (1–3 years). Economic losses can
then be estimated across a wide range of scenarios, using no
outbreak as a baseline.
Applications of this method using HPAI have been
demonstrated (e.g., Thurlow 2010; Diao et al. 2009;
Schmitz and Roy 2009). Economic losses due to avian
influenza outbreaks and the effect on economic growth
were estimated. Results suggested that demand shocks
driven by consumer panic is the largest factor in reduction
of poultry production, but the overall economic effect is
likely to be minimal due to small size of the poultry sector
and weak inter-sector linkages. The effect of an HPAI
outbreak on rural poor income is not significant due to a
diversified income portfolio with income from crops and
other livestock contributing to shock resilience. The impact
of HPAI on nutrition in Indonesian children was assessed
by Iannotti et al. (2008). It was noted that reduced poultry
product consumption resulting from a sustained HPAI
shock without an animal origin food substitute would have
significant detrimental impacts measured as growth stun-
ting, height for age, and hemoglobin concentration for
children (1–3 years old).
Microeconomic Impact Both qualitative and quantitative
analyses can be used to estimate the impact of zoonotic
disease outbreak on income and wealth of households.
Qualitative methods (focus group discussion, participatory
rapid appraisal) are useful to understand the flow of live-
stock products along the value chain and identify bottle-
necks, constraints or market failures and institutional risk
management strategies (policies and regulations), as well as
the social and political factors influencing livelihoods of
impoverished households. The impact of economic losses
on income generating activities, diversification patterns,
and dynamic changes in income generating activities can
also be investigated.
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Quantitative analysis of costs, income, and consump-
tion can be used to understand choices made by house-
holds and the effects on livelihood outcomes (increased
income and food security). The impact of zoonotic diseases
on household income and wealth can be estimated by
measuring the changes due to supply and demand shocks
and price changes with and without disease outbreaks. Data
for this type of analysis may not be available without a
household survey. In conducting a household survey, a
counterfactual (without disease outbreak) scenario has to
be identified against which the changes in livelihood out-
comes (with disease outbreak) can be measured. This in-
volves randomization of the sampling frame to maximize
quantitative accuracy and eliminate selection bias. Where
randomization is not possible, matching techniques, such
as propensity score matching in which two groups of
households with similar observable characteristics (house-
hold demographics, assets, income sources), can be used.
The two household groups consist of a treatment group
representing those with demand/supply shocks (with dis-
ease) and a control group representing the baseline (with-
out disease). The differences between these groups in
different scenarios of outcomes (income, productivity,
wealth) reveal the impact of zoonotic disease outbreaks on
income and wealth. Birol et al. (2010) used a similar ap-
proach to compare the impact of HPAI outbreak on live-
stock income and wealth by a scenario analysis.
Step 3: Assess the Cost-Effectiveness of Control
Strategies Currently Used to Reduce the Risk of
Human and Animal Exposure to Zoonotic Diseases
Methods for Evaluation of Control Measures
Prevention and control strategies help minimize negative
economic impacts of animal disease outbreaks, but there
are costs associated with implementation. The costs and
benefits of prevention and control measures must be as-
sessed to inform policy makers for development of effective
prevention and control policies.
Modeling the Direct Costs of a Disease Effects of disease on
livestock productivity (see above, assessing effects on live-
stock productivity) can be used to estimate direct cost of
disease. The direct costs of the disease will be assessed using
a partial budget model adapted from Bennett (2003). It is
assumed that the direct costs of the zoonotic disease are
additively related to loss in expected output, increase in
expenditure on non-veterinary resources due to the disease
and cost of inputs to prevent the disease.
Modeling Approach to Cost Benefit Analysis of the Interven-
tion
The costs and benefits of the impacts of an intervention can be
evaluated either in terms of public willingness to pay for them
(benefits) or willingness to pay to avoid them (costs) or in
terms of actual costs if control efforts have been implemented.
Cost benefit analysis (CBA) is useful for governments to
evaluate the desirability of a given intervention in markets. An
intervention would be considered Pareto optimal if it im-
proves the situation for some and does not worsen the situa-
tion of any. Pareto optimal solutions are difficult to achieve in
practice. Potential Pareto solutions recognize that those who
gain could compensate losers and still be better off and provide
decision makers with a mathematical way to determine effi-
cient interventions (Glauber and Narrod 2001). Acceptable
intervention policies for governments are reflected when:
E Benefitsð Þ  E Costsð Þ
Though CBA traditionally focuses on efficiency by pro-
viding policy makers with an indication of the magnitude of net
benefits associated with a particular policy, it is also possible to
track the distribution of costs and benefits within different
segments of the population. Ideally for zoonotic disease how
costs and benefits are distributed by sector or geographic
location would be determined. Therefore, the risk assessment
should identify the higher risk pathways and sectors.
Because uncertainty and variability exists with all
variables used in the CBA estimates it is important to
conduct sensitivity and scenario analyses to illustrate how
results change relative to the value of particular variables.
Cost-Effectiveness Analysis
Cost-effectiveness analysis aims to achieve the specified
goal with the smallest loss in social welfare recognizing that
the smallest loss might not be associated with the smallest
financial cost. Towards analyzing control options associ-
ated with zoonotic diseases, the objective of the CEA
analyses is to provide economic and disease risk and
information on the impact of an intervention (or set of
interventions). Certain strategies may have economies of
scale which favor large producers.
Roth et al. (2003) estimated the societal economic benefit,
cost-effectiveness, and distribution of benefit of improving
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human health through a brucellosis mass livestock vaccination
campaign in Mongolia. A livestock-human brucellosis trans-
mission model (Zinsstag et al. 2005a) was linked to a livestock
productivity analysis to evaluate the impact of a planned 10-
year livestock mass vaccination campaign to determine the
cost-effectiveness, expressed as cost per DALY averted. The
authors showed that if the costs of the intervention were
shared proportional to the benefit to each sector, the public
health sector would only contribute 11%, giving a cost-effec-
tiveness of 19.1 USD per DALY averted (95% confidence
interval 5.3–486.8). If private economic gain due to improved
human health was included, the health sector would con-
tribute 42% to intervention costs and cost-effectiveness would
decrease to 71.4 USD per DALY averted. The conclusion was
that if the costs of livestock vaccination were allocated to all
sectors in proportion to the benefits, the intervention might be
profitable and cost effective for the agricultural and health
sectors (Roth et al. 2003). Figure 3 summarizes the costs and
benefits of brucellosis control.
Step 4: Identify the Factors Preventing the Adoption
of Cost-Effective Strategies
Knowledge, Attitude, and Perception Analysis Surrounding
Zoonotic Disease
Knowledge, attitude, and practice (KAP) analysis is
increasingly used to evaluate the impact of education or
intervention programs. The knowledge refers to the degree
of understanding of the topic and associated issues, while
attitude refers to respondent’s feelings towards them. Per-
ception refers to the sense of awareness on the topic.
Practices refer to past and current actions towards the to-
pic. The KAP on zoonotic diseases has been investigated in
general populations (Fielding et al. 2005; Di Giuseppe et al.
2008) and target groups (Abbate et al. 2006; Leggat et al.
2007). These studies used a Likert scale in the surveys,
grouping questions into generalized groups where answers
to each question were scored with points summed across.
These KAP scores were then used to analyze the difference
between different socioeconomic groups by univariate and/
or multivariate analytical tools.
Recently Narrod et al. (2011) applied this approach to
factors affecting knowledge about symptoms of avian
influenza, attitudes on handling sick and dead birds, and
perception of disease transmission in four countries in
Africa. It was noted that production characteristics, rela-
tions with others and household characteristics influence
individual’s knowledge, attitude, and perception and that
in turn influences an individual’s behavior towards
adopting specific biosecurity actions (practices).
Willingness to Pay/Adopt Analysis Surrounding Zoonotic
Disease Control Analysis Assessing public willingness to
pay (WTP) is important in designing cost-effective mea-
sures to reduce disease risks and in estimating demand for
these measures. Valid estimates of WTP for disease risk
reduction are often used to inform the cost and benefits of
Figure 3. Costs and benefits of Brucellosis control in Mongolia (Roth et al. 2003). Intervention cost (black), public health benefits (oblique
lines), private health benefits (vertical lines), reduced household income loss (horizontal lines), agricultural benefits (white).
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technologies for prevention and control of zoonotic
diseases. The economic values of the benefits of these
technologies are not always known since most of these
technologies are not yet market-available or adopted by
consumers, so current prices may not reflect these ben-
efits. To estimate a valuation of these non-market goods
and to solicit consumers’ WTP for a product that is not
yet on the market, economists have used contingent
valuation (CV) methods originally developed in envi-
ronmental and natural resource economics (Mitchell and
Carson 1989). A hypothetical market is created for of the
non-market good or service, contingent a non-market
good or novel product, after which a group of subjects
are invited to operate in that market and the results are
recorded. The values generated through the use of the
hypothetical market are treated as estimates of the value
upon the particular hypothetical market (Mitchell and
Carson 1989).
WTP can be estimated using open-ended questions,
asking respondents to state the maximum amount they
would be willing to pay, or dichotomous questions, asking
the respondents if they would be willing to pay a specific
amount or not. The open-ended format can be used when
the consumer is well informed about the new product and
its characteristics, but might not return realistic estimates if
respondents do not have sufficient information to thor-
oughly consider the value attached to such goods if a
market were to exist (Arrow et al. 1993). Dichotomous
questions are easier for the respondent to assess and more
realistic as they correspond to a usual market situation. In
most markets, consumers are offered a product at a par-
ticular price and, perhaps after some bargaining, face a
decision to purchase or not. Efficiency can be improved by
offering the respondent a second bid, higher or lower
depending on the first response, in an approach generally
known as the double-bounded CV method (Hanemann
et al. 1991). In this method, consumers will be given a
hypothetical scenario involving the likelihood and severity
of the outcomes, for example the number of people in-
fected with rabies. Then consumers are presented with a
price to see if they are willing to pay a certain amount for a
definite safety level and, after responding yes or no, they are
then presented with a second price bid, higher or lower
than the first price. Finally, WTP can be modeled as a
function of the severity and duration of illness, reduction in
probability and respondent characteristics (Hammitt and
Haninger 2007).
DISCUSSION AND CONCLUSIONS
This article provides a comprehensive framework for
assessing the societal cost of zoonotic diseases across all
involved sectors. It is composed of novel joint methods to
assess zoonotic disease frequence in animals and humans
simultaneously, economic tools to estimate societal cost of
disease and a mathematical framework simulating animal–
human disease transmission, which can be used for com-
parative cost-effectiveness studies of interventions. For all
parts case studies exist but only few studies exist that cover
the whole range of the framework, e.g., a study on rabies in
N’Djame´na, Chad (Kayali et al. 2003; Durr et al. 2008;
Zinsstag et al. 2009b). The importance of understanding
the disease and host biology is highlighted because this is
central to all control strategies. These assessments must be
done in cooperation between epidemiologists, veterinari-
ans, medical doctors, economists, anthropologists, and
social scientists in the spirit of ‘‘one health’’, benefiting
from true closer cooperation across the human and animal
health sectors (Zinsstag et al. 2005b, 2009a). The advantage
of the framework is its potential for a comprehensive cross-
sector societal assessment. However, it requires advanced
capacity in epidemiology, economics, and mathematical
modeling. As most of the steps require data collection, such
an approach is costly and it may not always be feasible to
undertake an exhaustive analysis simultaneously. It is sug-
gested that research efforts be targeted at immediate needs,
with additional analyses added over time to gain all
information necessary for implementing effective control
strategies which ensure the poverty alleviation and com-
munity participation. One of the critical issues are that
most of the time household livelihood or patient-based
private cost of disease studies are missing. They are, how-
ever, required, as private cost of disease is an important
part of overall cost of disease, which is often higher than the
public cost. Local perceptions, attitudes, and practices are
often neglected because of the lack of capacity in cultural
and gender studies. The framework can be used as modules,
or in a reduced form using static instead of dynamic
models. In this way approximations can be obtained with
less resources and high level capacity. There remains,
however, no doubt that governments in developing coun-
tries need to be informed as good as possible on the
profitability and cost-effectiveness of interventions against
zoonoses, in order to use scarce resources in the best way.
Successful country specific zoonoses control is achievable
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over time within the framework. The framework’s ap-
proach has far reaching consequences because it includes all
involved sectors. Cross-sector approaches may be needed
not only when addressing health issues but also for envi-
ronmental and societal problem solving.
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